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    40 
Summary 41 
Background: An accurate, minimally invasive, ante-mortem, diagnostic test for equine grass sickness 42 
(EGS) is currently lacking. While histological examination of haematoxylin-eosin stained rectal biopsies 43 
for chromatolytic neurons is insensitive as a diagnostic test for EGS, it was hypothesised that the 44 
diagnostic accuracy could be improved by immunolabelling for β-amyloid precursor protein (β-APP) 45 
which has increased expression in cranial cervical ganglia (CCG) neuronal perikarya in EGS.  46 
Objectives: To develop a grading scheme for assessing the distribution and intensity of β-APP 47 
immunoreactivity within individual rectal submucosal neurons and subsequently determine the 48 
diagnostic value of the distribution of different grades of neurons for EGS diagnosis.  49 
Study design: Retrospective case-control diagnostic accuracy study.  50 
Methods: Initially a standardised grading scheme was developed and β-APP immunoreactivity in 51 
individual neuronal perikarya and axons was compared in sections of CCG and ileum from EGS and 52 
control horses. The grading scheme was further refined before being blindly applied to submucosal 53 
neurons in rectal biopsies derived from 21 EGS and 23 control horses. 54 
Results: β-APP immunoreactivity was increased in neuronal perikarya and axons in sections of CCG, 55 
ileum and rectum from EGS horses compared with controls. For rectal biopsies, a mean 56 
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immunoreactivity grade exceeding 1.1 was 100% specific and sensitive for EGS, and the presence of 57 
at least one neuron with diffuse labelling of the entire cytoplasm (grade 3) was 95% sensitive and 100% 58 
specific for EGS.  59 
Main limitations: While the diagnostic criteria facilitated discrimination of the EGS and control biopsies 60 
evaluated in this study, further prospective validation using a larger sample set is required.  61 
Conclusions: Histological assessment of β-APP immunolabelled rectal biopsies is more sensitive than 62 
conventional histological examination for EGS diagnosis. Further validation is required before this 63 
technique can be advocated for clinical decision making. 64 
 65 
Introduction 66 
A sensitive, minimally invasive, ante-mortem, diagnostic test for equine grass sickness (EGS) is 67 
currently lacking. Such a test would facilitate appropriate case management by aiding EGS diagnosis, 68 
which is currently challenging in some cases, and avoid the necessity for invasive ileal biopsy. The 69 
presence of chromatolytic neurons in rectal submucosa of EGS horses [1-4] indicates that histological 70 
assessment of rectal biopsies could potentially provide a relatively simple, minimally invasive and 71 
inexpensive ante-mortem diagnostic technique. Histological examination of two full-thickness, 72 
haematoxylin-eosin (H&E) stained sections of rectum collected post-mortem yielded a sensitivity of 71% 73 
and specificity of 100% for EGS diagnosis, when the diagnostic criterion was identification of at least 74 
three chromatolytic neurons [3]. However, a later study found that histological examination for 75 
chromatolytic neurons in (H&E) stained rectal biopsy sections is insensitive (21% sensitivity) for EGS 76 
diagnosis [4]. The diagnostic value of rectal biopsies in EGS diagnosis is potentially limited by small 77 
sample size, paucity of neurons in rectal submucosal plexi, difficulty in histological recognition of 78 
chromatolytic neurons, and crush artefacts. It was suggested that application of specific neuronal 79 
labelling may overcome some of these limitations thereby increasing the diagnostic utility [4]. Whilst 80 
synaptophysin immunolabelling of ileal sections facilitates correct differentiation of control and EGS 81 
cases [5] ,synaptophysin immunolabelling of rectal sections provides no further diagnostic sensitivity 82 
compared to H&E stained rectal sections (E. M. Milne, unpublished observation).  83 
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This study tested the hypothesis that immunolabelling with β-amyloid precursor protein (β-APP), which 84 
accumulates in cranial cervical ganglion (CCG) neuronal perikarya in EGS [6], would improve the 85 
accuracy of histological assessment of rectal biopsies for EGS diagnosis. β-APP is an extensively post-86 
translationally modified and proteolytically cleaved transmembrane protein, associated with synaptic 87 
formation and repair, present at high concentrations within neurons [7]. Increased β-APP expression is 88 
part of the acute phase response to neuronal injury [8], occurring in acquired diseases [9; 10], in various 89 
neurodegenerative conditions [11] including Alzheimer’s disease [12], Down’s Syndrome [13] and 90 
tauopathies [14] and in murine neurodegenerative disease models [15]. The expression of β-APP is 91 
therefore not specific for EGS. 92 
The purpose of this study was to develop and refine a grading scheme for assessing the distribution 93 
and intensity of β-APP immunoreactivity within individual neuronal perikarya and axons in rectal 94 
biopsies and subsequently determine the best diagnostic predictor for discriminating EGS and control 95 
horses. Initially sections of ileum and CCG, were utilised to establish a grading scheme for assessing 96 
β-APP immunoreactivity prior to evaluating the rectal submucosal plexi which has fewer neurons [1; 2]. 97 
Neuronal pathology is not uniform throughout the gastrointestinal tract in EGS, and the ileum has 98 
consistently been reported to be most severely affected region [1; 2; 16]. Histopathological examination 99 
of formalin-fixed, H&E stained CCG is regarded as the “gold standard” diagnostic test for EGS [2; 17; 100 
18], while histopathological examination of formalin-fixed, H&E stained ileal sections offers up to 100% 101 
sensitivity and specificity [16].  102 
 103 
Materials and Methods  104 
Collection of tissue samples  105 
Tissue samples were collected ante-mortem from EGS and control horses for routine clinical diagnostic 106 
purposes or, with the horse owners’ consent, post-mortem from horses subjected to euthanasia. All 107 
ileal [19], CCG [6; 19] and some EGS rectal biopsies [4] were available from previously reported studies. 108 
All the control and remaining EGS rectal biopsies were collected prospectively. Horses were of mixed 109 
breeds and sex. EGS was confirmed by post-mortem examination including conventional 110 
histopathological examination of H&E stained CCG and/ or ileum [2; 16-18; 20; 21], by specialist 111 
pathologists experienced in EGS diagnosis. EGS was categorised as previously described [22; 23]. In 112 
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summary, acute EGS cases had mild to moderate abdominal pain with gastric and small intestinal 113 
distension, subacute EGS cases had less severe signs, a more insidious onset and secondary large 114 
intestinal impactions, and chronic cases had none of these sequelae. All control cases with colic had a 115 
physical lesion identified at exploratory laparotomy. All other control horses had no ante-mortem clinical 116 
evidence of EGS and were subjected to euthanasia for unrelated reasons (see results). Thorough 117 
clinical examinations were performed, by clinicians experienced in EGS diagnosis, and specifically the 118 
control horses had no evidence of tachycardia, ptosis, muscle fasciculations, patchy sweating, 119 
dysphagia, base narrow stance or weight loss with ‘tucked up’ abdominal silhouette. The reported 120 
median age for EGS horses of 5 years [24] was considered when selecting cases for control rectal 121 
biopsies, such that there would be no significant inter-group difference in age. CCG and full thickness 122 
ileal samples were collected post-mortem within 3.5 h of death. Rectal biopsies were collected using 123 
uterine biopsy forcepsa as described previously [4]. Post-mortem rectal biopsies were collected within 124 
10 min of death. Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin wax, and 125 
4μm sections cut. A single section from each rectal biopsy contributed to a single histology slide for 126 
each horse.  127 
Immunohistochemistry 128 
Immunohistochemistry was done as previously reported [6] and as detailed in Supplementary item 1. 129 
Grading of neuronal and axonal immunolabelling 130 
Cranial cervical ganglion and ileum 131 
See Supplementary item 2.  132 
Rectum 133 
Preliminary screening of rectal samples indicated that the grading scheme developed using the CCG 134 
and ileal sections was insufficiently precise to facilitate repeatable  grading of the immunolabelling of 135 
individual neurons, and in particular to  differentiate grade 2 and grade 3 neurons. Further refinement 136 
of the grading scheme to facilitate repeatableassessment of the intensity and distribution of 137 
immunolabelling of individual neurons was achieved by detailed assessment of the immunolabelling of 138 
individual neurons in a randomly selected subset of rectal sections, with no regard to disease status. 139 
Consequently, the derivation of the neurons (i.e. EGS or control horses) had no bearing on the grading 140 
refinement process. When applying the refined grading scheme, grade 3 neurons, in contrast to grade 141 
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2 neurons, were classified as those with diffuse labelling of the entire cytoplasm, extending right up to 142 
the perikaryonal margin, except when this was displaced by cytoplasmic vacuolation (Fig 1). This 143 
grading system was then applied by a single observer (RJ, equine internal medicine senior clinical 144 
scholar) in the blinded assessment of all rectal biopsy sections. In all sections, all submucosal plexus 145 
neurons containing nuclei were graded, identifying neurons with x10 objective and grading individual 146 
neurons with x40 objective.  147 
All rectal biopsy sections were blindly assessed on a second occasion by the same author (RJ) and by 148 
a specialist in veterinary pathology (SS), to assess intra- and inter-observer agreement, respectively, 149 
to determine the repeatability of the proposed rectal biopsy grading scheme. 150 
 151 
Data analysis 152 
Age, number of rectal biopsies per horse and number of neurons counted per horse were described 153 
using medians and interquartile ranges (IQR). For each horse the distribution of different grades of 154 
neuron was determined and a mean immunoreactivity grade calculated.. Mann-Whitney U test was 155 
used for inter-group (control vs EGS, ante-mortem vs post-mortem sample collection, chronic vs 156 
subacute vs acute) comparisons of these variables. Using conventional histopathological examination 157 
of H&E stained CCG [2; 17; 18; 20] and ileum [16; 21] as the reference tests for EGS diagnosis, the 158 
sensitivity and specificity of EGS diagnosis using histological assessment of β-APP immunoreactivity 159 
of rectal biopsies was calculated. The predictive value of the distribution of different grades of neurons 160 
and of the mean immunoreactivity grade for EGS diagnosis was determined by constructing receiver 161 
operating characteristic (ROC) curves including estimation of area under the curve (AUC). An optimal 162 
cut-off was proposed by identifying a point that would give maximum sensitivity with an estimated 163 
specificity of 1.0. A specificity of 1.0 was selected (i.e. no false positives within the study data) to 164 
minimise the possibility of an erroneously diagnosed EGS horse being inappropriately euthanised. The 165 
number of neurons required to be evaluated per horse to be confident that a grade 3 neuron was or 166 
was not present, at the expected median prevalence was calculated using a surveillance design toolb. 167 
The total estimated number of neurons within the rectum required for this calculation was calculated 168 
assuming that neuronal density is uniform throughout the length of the rectum [2], the diameter of 169 
submucosal neuronal perikarya was 25μm, and rectal length and diameter was 30 and 7cm respectively 170 
[25]. Using the criterion for EGS diagnosis as the presence of at least one grade 3 rectal neuron, kappa 171 
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statistics were calculated for the intra- and inter-observer agreement in the interpretation of cases (EGS/ 172 
control), using a diagnostic design toolb. GraphPad Prismc was used for all statistical analyses described 173 
above, unless specifically stated otherwise. P<0.05 was used as the threshold for statistical 174 
significance. This study conformed to Standards for the Reporting of Diagnostic Accuracy (STARD) 175 
guidelines where appropriate.  176 
  177 
Results 178 
CCG and ileal sections 179 
See Supplementary item 2. 180 
Rectal biopsy sections  181 
Rectal biopsies comprised 21 EGS (6 acute, 12 sub-acute and 3 chronic) and 23 control horses. Eight 182 
EGS samples were collected ante-mortem and the remainder post-mortem. Samples from two control 183 
horses (one with weight loss and one with chronic diarrhoea) were collected ante-mortem and the 184 
remainder post-mortem. Reasons for euthanasia for controls collected post-mortem were behavioural 185 
(n=1), colic (n=4), neurological (n=4), recurrent uveitis (n=1), orthopaedic (n=7) and elderly horses 186 
donated for research (n=4). There was no significant difference in age of control and EGS horses from 187 
which rectal biopsies were collected (Supplementary item 3).  188 
All rectal biopsy sections comprised mucosa, submucosa with the submucosal plexus, but no myenteric 189 
plexus. Significantly more rectal biopsies were collected from controls (median 4; IQR 4-5) than from 190 
EGS horses (median 2; IQR 2-2), resulting in a significantly higher total number of neurons counted in 191 
control sections (median 187; IQR 111-308) than in EGS sections (median 70; IQR 46-115). However, 192 
average number of neurons per section was not significantly different between EGS (median 37: IQR 193 
23-58) and control (median 46; IQR 24-58) horses.  194 
EGS horses had significantly lower percentages of grade 0 neurons and significantly higher 195 
percentages of grade 1, 2 and 3 neurons (Fig 1 & 2, Table 1, Supplementary items 4). Grade 3 neurons 196 
were not observed in control horses, but were observed in all but one EGS case. Very occasional 197 
adjacent nerve processes were labelled, but none were detected in the mucosa.  198 
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While most EGS and control rectal sections could be readily differentiated based on the intensity and 199 
distribution of neuronal β-APP immunoreactivity using the criteria of >5% grade 3 neurons (EGS), >40% 200 
grade 0 neurons (control) and high proportion of grade 2 neurons (EGS) (Fig 2), a sub-population of 201 
samples (n=9, highlighted in red in Supplementary item 4) were considered to be equivocal. The 202 
equivocal cases included 2 controls with a lower percentage of grade 0 neurons and higher percentage 203 
of grade 1 neurons, compared to the other controls. Both these cases were sampled ante-mortem; one 204 
for investigation of chronic diarrhoea and the other for investigation of weight loss. The 7 equivocal EGS 205 
cases were 1 acute, 3 subacute and 3 chronic EGS cases, which had <4% grade 3 neurons. Whilst 206 
these cases would be equivocal in a clinical situation there was no overlap in the mean immunoreactivity 207 
grade for neurons in EGS and control horses whereas the percentage of grade 1 neurons had the 208 
greatest degree of overlap between EGS and control horses, and all other diagnostic determinants were 209 
similar (Table 1). Consequently, the AUC of the ROC curves was highest for mean immunoreactivity 210 
grades (with a value exceeding 1.1 being indicative of EGS). When the specificity was set at 1.0, the 211 
highest diagnostic sensitivity for EGS diagnosis was a mean immunoreactivity grade exceeding 1.1 (1.0 212 
sensitivity) and a percentage of grade 3 neurons exceeding 0.75% (0.95 sensitivity). Using the presence 213 
of at least one neuron with diffuse labelling of the entire cytoplasm (grade 3) in rectal biopsies as the 214 
criterion for EGS diagnosis yielded a 95% sensitivity and 100% specificity for EGS diagnosis.  215 
The mean immunoreactivity grade for EGS samples collected ante-mortem (median 2.03; IQR 1.46-216 
2.62) was not significantly different (p=0.089) to that for samples collected post-mortem (median 1.58; 217 
IQR 1.22-1.84). Further analyses were not performed for control samples as only 2 were collected ante-218 
mortem. The median number of total neurons per section was higher in chronic cases (median 60; IQR 219 
27-69.5) than acute/ subacute cases (median 34; IQR 23-49); however the difference was not 220 
significant.  221 
The median prevalence of grade 3 neurons in EGS horses was 11.4% (Table 1). The total estimated 222 
population of submucosal neurons which could be biopsied within the rectum was 23-46,000,000 per 223 
horse, depending whether each nucleus was in 1 or 2 adjacent sections. If the total population of 224 
submucosal neurons that could be sampled by a rectal biopsy is >5000, grading of at least 30 neurons 225 
would be required to have 96% confidence that a grade 3 neuron was or was not present at the expected 226 
median prevalence of 11.4% (20 neurons = 89%, 50 neurons = 99.6% confidence).  227 
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The kappa statistic was 1.0 (1.0-1.0 lower and upper 95% limit) and 0.95 (0.87-1.04), respectively for 228 
the intra- and inter-observer agreement in the interpretation of each case.  229 
Non-neuronal labelling and artefacts 230 
Intimal asteroid bodies [26] were unlabelled in the antibody negative method control sections but were 231 
immunopositive in antibody positive sections (Fig 3a). This labelling was readily differentiated from 232 
positive neuronal labelling because of their location, protruding into the lumen of small arterioles and 233 
lack of nucleus. Pigment granules (haemosiderin and/ or lipofuscin) within macrophages were evident 234 
in the submucosa of some horses, and could be distinguished from immunolabelling by the 235 
characteristics of the pigment, presence in corresponding control sections and characteristics of cell 236 
morphology (Fig 3b). Oval particles of plant debris were occasionally translocated from the lumen during 237 
the biopsy procedure and could readily be differentiated by morphological characteristics including the 238 
absence of nuclei (Fig 3c). 239 
  240 
Discussion 241 
β-APP immunoreactivity was increased in neuronal perikarya and axons in sections of CCG, ileum and 242 
rectum from EGS horses compared with controls. These data extend previous findings of increased β-243 
APP immunoreactivity in CCG sections and increased expression of β-APP in CCG protein extracts in 244 
EGS [6].  245 
β-APP is synthesised in the endoplasmic reticulum and transported through the Golgi apparatus, 246 
plasma membrane and axons [7]. The pattern of labelling observed in control rectal submucosal 247 
neurons (Fig 1: grade 1) is consistent with this normal cellular processing of β-APP, and is similar to 248 
that observed in other neuronal populations. In contrast, some neurons in EGS horses had intense 249 
granular to diffuse labelling throughout the cytoplasm (Fig 1), indicating abnormal accumulation of β-250 
APP; consistent with dysfunction and degradation of membrane-bound compartments. This study 251 
confirms previous work [6] that EGS is associated with accumulation of β-APP in perikarya of 252 
degenerate neurons, in adjacent nerve processes and in intra-ganglionic axons, but not in larger nerve 253 
fascicles. Potentially this may reflect (a) upregulation of neuronal synthesis of these proteins, (b) 254 
reduced catabolism of β-APP, (c) dysfunction of glycoprotein processing in the Golgi network, and/or 255 
(d) failure of axonal transport of protein-containing vesicles to the nerve terminal. Accumulation of β-256 
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APP in the perikarya and intra-ganglionic axons, but not in larger nerve fascicles is consistent with the 257 
latter. Consistent with the latter two hypotheses, ultrastructural loss of a recognizable Golgi structure is 258 
a likely early event in EGS, and EGS is associated with major perturbations in the cytoskeleton of 259 
autonomic neurons resulting in accumulation of dopamine-β-hydroxylase and presynaptic proteins in 260 
neuronal perikarya [19; 27; 28]. β-APP has been described as a marker of early axonal injury prior to 261 
apparent histological changes in routine H&E sections [29].   262 
Evaluation of β-APP immunolabelled rectal biopsy sections using a standardised grading scheme can 263 
aid diagnosis of EGS. Indeed, for the sections evaluated in this study, a mean immunoreactivity grade 264 
exceeding 1.1 was 100% specific and sensitive for EGS, and the presence of at least one neuron with 265 
diffuse labelling of the entire cytoplasm (grade 3) was 95% sensitive and 100% specific for EGS. This 266 
diagnostic accuracy is comparable to that of conventional histological examination of ileal biopsies [16; 267 
21] which has a sensitivity and specificity of 100% [16] and is significantly higher than that of 268 
conventional histological examination of two rectal biopsies (sensitivity 21%) [4]. However, it should be 269 
stressed that further validation of this technique is required prior to its application to clinical cases.  270 
A subset of CCG, ileal and rectal biopsy samples were pre-screened in order to establishgrading 271 
schemes and to identify non-neuronal staining, prior to blinded evaluation. Individual neuronal perikarya 272 
and axons were used as examples of β-APP immunolabelled neurons to facilitate development and 273 
refinement of the grading schemes, with absolutely no bearing on whether the neurons were derived 274 
from control or EGS sections. The grading scheme was then applied blindly to determine which grading 275 
parameter had the greatest diagnostic accuracy in discriminating EGS and control sections.  276 
A limitation of the study was that although the diagnostic criteria facilitated differentiation of EGS and 277 
control rectal samples in this sample set, further development and prospective validation of both the 278 
grading scheme and the diagnostic criteria using larger numbers of EGS and control samples is 279 
necessary before the diagnostic value of this approach can be fully advocated.  280 
Whilst the sub-population of equivocal samples would have been correctly classified using the criteria 281 
of mean immunoreactivity grade exceeding 1.1, in a clinical situation, there would be a degree of 282 
uncertainty in their assessment. Consequently, the use of these criteria in a clinical situation would have 283 
reduced the confidence in a diagnosis based solely on this diagnostic approach, a significant 284 
consideration in light of the fact that a false positive result could prompt euthanasia of a horse without 285 
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EGS. It is important to note however, that these samples would have been highlighted as equivocal and 286 
not erroneously diagnosed. Further work is therefore required to optimise differentiation of the equivocal 287 
sub-population of samples. While a mean immunoreactivity grade exceeding 1.1 was 100% specific 288 
and sensitive for EGS, there are limitations to the use of this criterion for EGS diagnosis. Firstly there 289 
was very little difference between the highest mean immunoreactivity grade for control horses (1.057) 290 
and the lowest mean immunoreactivity grade for EGS horses (1.137) (Supplementary item 4); 291 
consequently, it is possible that this criterion may not be fully discriminatory when a larger sample size 292 
is prospectively evaluated. Further limitations of this criterion are that it is laborious to determine and 293 
likely subject to a degree of inter-observer variability.  294 
Similarly, while the presence of at least one grade 3 neuron was 95% sensitive and 100% specific for 295 
EGS, use of this criterion is potentially limited by errors in differentiating grade 2 and grade 3 neurons. 296 
To reduce this error, very repeatable grading criteria were developed and applied, such that grade 3 297 
neurons had diffuse labelling of the entire cytoplasm, extending right up to the perikaryonal margin, 298 
except when this was displaced by cytoplasmic vacuolation (Fig 1). This potential limitation is 299 
confounded by the relative paucity of grade 3 neurons in rectal biopsies of EGS cases (median 11.4% 300 
of neurons, IQR 2.8-42) compared to CCG (median 35.5, IQR 21-41). Consequently, EGS diagnosis 301 
was based on the presence of only a few grade 3 neurons, and in occasional cases only 1 grade 3 302 
neuron (n=2 horses). Chromatolytic neurons have been reported in the coeliacomesenteric ganglia, 303 
jejunum, ileum and small colon in clinically normal horses [2]. Whilst the assessment of chromatolysis 304 
is subjective, and relatively objective immunolabelling grading criteria may reduce the likelihood of 305 
incorrectly classifying neurons, a larger sample size is required to determine if grade 3 neurons are 306 
ever present in control horses. Although increasing the threshold for the diagnosis of EGS to the 307 
presence of ≥4 grade 3 neurons would increase the diagnostic certainty, it would also reduce the 308 
sensitivity to 62% (Supplementary item 5).  309 
CCG, ileal and rectal neurons from EGS horses, but not control horses, had pyknotic nuclei (Fig 1c). 310 
Further study is required to determine whether this conventional histopathological analysis for 311 
morphologic features of neurodegeneration, together with chromatolysis and neuronal swelling, could 312 
be incorporated into the grading scheme to improve diagnostic accuracy of rectal biopsies.  313 
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There was complete intra-observer and very good inter-observer agreement in the interpretation of 314 
cases. The single case that was not agreed upon was an equivocal EGS case which had only 1 grade 315 
3 neuron. In a clinical situation, it is unlikely that a diagnosis of EGS would be made upon observation 316 
of a single grade 3 neuron and further criteria or assessment of additional sections are required to give 317 
greater confidence differentiating the equivocal sub-population of samples.  318 
Further work is required to assess the effect of EGS category on neuronal β-APP immunoreactivity. 319 
Consistent with previous work [1; 2; 17; 18], a higher proportion of normal neurons was found in chronic 320 
cases; all 3 chronic EGS sections had significantly fewer grade 3 rectal neurons than acute and sub-321 
acute cases. Consistent with a further study [2], the median number of total neurons per section was 322 
higher in chronic cases than acute/ subacute cases; however the difference was not statistically 323 
significant and data from more chronic cases should be assessed to further investigate these findings. 324 
Acute and subacute forms of the disease are invariably fatal, while some cases of chronic EGS survive 325 
with appropriate nursing [24; 30-33]. A larger data set of chronic cases is required to investigate the 326 
potential prognostic value of β-APP immunolabelling.  327 
Whilst estimations indicate that at least 30 neurons must be examined to be 96% confident that a grade 328 
3 neuron was or was not present, at the expected median prevalence of 11.4%, it is likely that the 329 
diagnostic value of rectal biopsies and the confidence in the diagnosis could be improved by increasing 330 
the number of biopsies collected from each horse, and by examining multiple non-serial sections cut 331 
from individual biopsies. Previous studies indicate that the density of submucosal neurons does not 332 
have a consistent circumferential pattern in rectal samples [3], indicating that collection of biopsies from 333 
specific locations around the circumference of the rectal wall cannot reliably maximise the number of 334 
neurons sampled. While the total number of neurons identified in control rectal cases exceeded that of 335 
EGS cases, this reflected the increased number of biopsies collected from controls. Consequently there 336 
was no intergroup difference in the median number of neurons per section. The median number of 337 
rectal biopsies collected for EGS horses was comparable to the previous study by Mair et al. [4]. More 338 
biopsies were collected from control horses to increase the confidence of the calculated specificities.  339 
The effect of ante-mortem versus post-mortem sampling must be further evaluated. Both control 340 
samples that were collected ante-mortem had lower percentages of grade 0 neurons and were the only 341 
control cases that were classified as equivocal. Whilst there was a difference of 0.45 between the 342 
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median mean immunoreactivity grade of EGS samples collected ante- and post-mortem, the difference 343 
was not significant. 344 
The use of relatively non-invasive rectal biopsies versus ileal biopsies collected at laparotomy to 345 
diagnose EGS offers economic, welfare and time benefits. A disadvantage is the increased time 346 
required for immunolabelling of rectal biopsies compared with haematoxylin-eosin staining of ileal 347 
biopsies; total sample fixing and processing times being, respectively, a minimum of 12h and 6h. The 348 
timescale may be appropriate for ante-mortem diagnosis of sub-acute and chronic EGS cases and post-349 
mortem confirmation of EGS in horses that are subjected to euthanasia in the field when the invasive 350 
removal of CCG or ileum is not feasible. However, this technique may be unsuitable for rapid ante-351 
mortem diagnosis of acute EGS, unless the time requirement can be reduced, perhaps by using 352 
accelerated fixation protocols, frozen sections and employing rapid immunolabelling techniques.  353 
In conclusion, this work has demonstrated the potential diagnostic value of immunolabelled rectal 354 
biopsies for EGS diagnosis. However, further prospective studies are required before the use of this 355 
technique can be fully advocated in clinical decision making.  356 
Manufacturers’ addresses 357 
aEquivet uterine biopsy forceps; Kruuse UK Ltd, Sherburn in Elmet, UK 358 
bhttp://epitools.ausvet.com.au  359 
cGraphPad Software, La Jolla, California   360 
 361 
Figures  362 
Fig 1: Grading scheme used to assess β-amyloid precursor protein immunolabelling of neuronal 363 
perikarya in rectal submucosal ganglia. Grade 0= no labelling (blue arrowheads); 1= sparse labelling 364 
involving less than half of the cytoplasm (blue arrows); 2= greater than half of the cytoplasm is labelled 365 
but areas of unlabelled cytoplasm are still discernible (black arrowhead); and 3= diffuse labelling of 366 
entire cytoplasm right up to perikaryonal margin with no discernible unlabelled cytoplasm (black arrows).  367 
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 368 
A: Control horse: the majority of neurones are grade 0; the example of grade 1 labelling (blue arrow) 369 
was not included in the analysis as the nucleus of the neurone is not in the plane of the section.  370 
B: Grass sickness horse: examples of all immunolabelling grades present. 371 
C: Grass sickness horse: immunolabelling of neurones varies from grade 1-3; note the grade 3 neurone 372 
has peripheral cytoplasmic vacuolation and a shrunken (pyknotic) nucleus compared with the other 373 
neurones in the ganglion.  374 
Bars = 10µm. 375 
Fig 2: Percentage distribution of rectal submucosal neuronal grades for individual horses (Control = 376 
blue dot, equine grass sickness (EGS) = green dot and red cross = median). 377 
 378 
Fig 3: Examples of non-neuronal labelling and pigment artefacts (a) vascular intimal asteroid bodies 379 
(bar = 10µm), (b) macrophages containing intracytoplasmic pigment (bar = 10 µm), and (c) foreign 380 
(plant) material adjacent to mucosa (bar = 20µm).  381 
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 382 
Tables 383 
Table 1: Diagnostic determinants with associated areas under the receiver operating characteristic 384 
curve (AUC), and highest achievable sensitivity, when specificity was set at 1.0, and the thresholds that 385 
were set to achieve this, for the diagnosis of EGS.  386 
EGS = equine grass sickness, IQR = interquartile range, CI = confidence interval  387 
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